Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 17.76% is 83% above its 5-year average of 9.70%, near the high end of its 5-year range (0.00%–17.76%).
As of the fiscal period ended Wednesday, December 31, 2025. 44.33% above its 12-month average of 12.30%.
Annual fiscal-year return on invested capital; no daily interpolation.
RETURN ON INVESTED CAPITAL (ROIC)
17.76%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
12.30%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
11.68%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
9.70%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+44.33%
CURRENT VS 3Y AVG
+52.09%
CURRENT VS 5Y AVG
+83.12%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
8.53%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+108.21%
vs the sector median at left
Solventum Corporation
Market Cap
$14.80B
Return on Invested Capital (ROIC)
17.76%
TTM Avg
12.30%
3Y Avg
11.68%
5Y Avg
9.70%
Market Cap
$15.41B
Return on Invested Capital (ROIC)
10.58%
TTM Avg
10.99%
3Y Avg
9.48%
5Y Avg
9.31%
Market Cap
$14.10B
Return on Invested Capital (ROIC)
3.98%
TTM Avg
4.09%
3Y Avg
3.90%
5Y Avg
4.29%
Market Cap
$13.51B
Return on Invested Capital (ROIC)
-1.79%
TTM Avg
-0.86%
3Y Avg
-2.61%
5Y Avg
0.30%
Market Cap
$16.11B
Return on Invested Capital (ROIC)
67.94%
TTM Avg
52.59%
3Y Avg
46.08%
5Y Avg
35.95%
Market Cap
$16.97B
Return on Invested Capital (ROIC)
7.35%
TTM Avg
8.59%
3Y Avg
9.78%
5Y Avg
13.56%
Market Cap
$12.55B
Return on Invested Capital (ROIC)
2.82%
TTM Avg
2.97%
3Y Avg
3.42%
5Y Avg
5.50%
Market Cap
$12.11B
Return on Invested Capital (ROIC)
9.94%
TTM Avg
9.96%
3Y Avg
10.13%
5Y Avg
11.66%
Market Cap
$11.45B
Return on Invested Capital (ROIC)
13.62%
TTM Avg
12.65%
3Y Avg
8.97%
5Y Avg
7.27%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Solventum Corporation (SOLV) | $14.80B | 17.76% | 12.30% | 11.68% | 9.70% |
| DaVita Inc. (DVA)vs › | $15.41B | 10.58% | 10.99% | 9.48% | 9.31% |
| The Cooper Companies, Inc. (COO)vs › | $14.10B | 3.98% | 4.09% | 3.90% | 4.29% |
| Baxter International Inc. (BAX)vs › | $13.51B | -1.79% | -0.86% | -2.61% | 0.30% |
| Medpace Holdings, Inc. (MEDP)vs › | $16.11B | 67.94% | 52.59% | 46.08% | 35.95% |
| Hologic, Inc. (HOLX)vs › | $16.97B | 7.35% | 8.59% | 9.78% | 13.56% |
| Revvity, Inc. (RVTY)vs › | $12.55B | 2.82% | 2.97% | 3.42% | 5.50% |
| Align Technology, Inc. (ALGN)vs › | $12.11B | 9.94% | 9.96% | 10.13% | 11.66% |
| Insulet Corp. (PODD)vs › | $11.45B | 13.62% | 12.65% | 8.97% | 7.27% |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $18.17B | 5.48% | 5.58% | 5.01% | 3.94% |
ROIC
17.8%
ROE
28.8%
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | 17.76% |
| 2024-12-31 | 6.85% |
| 2023-12-31 | 11.18% |
| 2022-12-31 | 10.92% |
| 2021-12-31 | 11.48% |
| 2020-12-31 | 0.00% |
